Angiography Equipment Market Report 2025

The angiography equipment market size has grown strongly in recent years. It will grow from $13.05 billion in 2024 to $13.94 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to rising cardiovascular diseases, minimally invasive procedures, aging population, healthcare infrastructure development, clinical research and development.

The angiography equipment market size is expected to see strong growth in the next few years. It will grow to $19.29 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to integration with hybrid ORs, data security and privacy, globalization of healthcare services, patient-centric care, personalized healthcare. Major trends in the forecast period include global healthcare accessibility, remote consultation and training, value-based healthcare models, data security and interoperability, customization and tailored solutions.

The angiography equipment market is expected to see significant growth due to the rising frequency of cardiovascular illnesses. Cardiovascular diseases (CVD) involve the use of X-ray imaging to identify obstructed or constricted cardiac blood vessels, making angiography an essential diagnostic tool. According to a report by PCRonline in September 2023, approximately 620 million people worldwide are currently living with heart and circulatory diseases, with around 60 million new cases diagnosed each year. This highlights the substantial global burden of cardiovascular conditions, indicating a strong demand for effective diagnostic and treatment solutions. As a result, the increasing prevalence of cardiovascular illnesses is likely to drive the growth of the angiography equipment market in the coming years.

Growing healthcare expenditure is playing a crucial role in the expansion of the angiography equipment market. Increased spending on healthcare - by both governments and individuals - facilitates the adoption of advanced medical technologies, including angiography systems. For example, in July 2024, the American Medical Association reported that U.S. health spending rose by 4.1% in 2022, totaling $4.5 trillion, which equates to approximately $13,493 per person. This significant investment in healthcare indicates a commitment to improving medical facilities and technologies, thereby driving the demand for angiography equipment. Consequently, the rising healthcare expenditure is expected to propel the growth of the angiography equipment market in the future.

A significant trend observed in the angiography equipment market is focused on product innovation. Leading companies in this sector are concentrating on developing novel and advanced solutions to fortify their market position. For example, in June 2022, Shimadzu Medical Systems, a US-based manufacturer specializing in advanced imaging systems, introduced the Trinias angiography system. This cutting-edge system incorporates artificial intelligence (AI) deep learning technology and operates at reduced X-ray doses, approximately 40% lower than previous models. Notably, this angiography system is the first to integrate AI into its image-processing engine, delivering an expanded feature set that streamlines workflow, thereby enhancing clinical operations within medical facilities.

Leading companies in the angiography equipment market are prioritizing the integration of artificial intelligence (AI) and machine learning to enhance the accuracy of their equipment for the early detection of cardiovascular diseases. AI algorithms can aid in interpreting images, improving diagnostic accuracy, and streamlining workflow efficiency. For example, in October 2023, Abbott, a US-based healthcare and medical devices firm, introduced the Ultreon 1 Software, a notable advancement in angiography technology tailored for Optical Coherence Tomography (OCT) applications in interventional cardiology. By combining artificial intelligence (AI) with cutting-edge imaging, the software enhances decision-making processes during percutaneous coronary interventions (PCI). Ultreon 1 employs OCT technology to provide physicians with detailed cross-sectional images of coronary arteries, allowing for a more precise evaluation of plaque and coronary artery disease compared to conventional angiography, which facilitates quicker and more accurate stent placements.

In October 2023, Abbott, a US-based healthcare company, revealed its acquisition of Cardiovascular Systems, Inc. for an undisclosed amount. This acquisition is intended to enhance Abbott’s portfolio in the cardiovascular sector and meet the increasing demand for innovative treatments for cardiovascular diseases worldwide. Cardiovascular Systems, Inc. is a US-based medical device firm that specializes in developing and providing angiography equipment, with a particular emphasis on innovative solutions for treating peripheral artery disease (PAD) and coronary artery disease (CAD).

Major companies operating in the angiography equipment market are GE HealthCare Technologies Inc., Koninklijke Philips N.V., Siemens Healthineers AG, Canon Corporation, Boston Scientific Corporation, Cordis Corporation, Shimadzu Corporation, Medtronic PLC, Angiodynamics, B. Braun Melsungen, Abbott Laboratories, Terumo Corporation, Toshiba Medical System Corporation, Merit Medical Systems Inc., Hitachi Medical Systems, Carestream Health, Hologic Inc., Guerbet S.A., Bracco Imaging SpA, Lantheus Medical Imaging Inc., Esaote SpA, Mindray Medical International Limited, Neusoft Medical Systems Co. Ltd., Samsung Medison Co. Ltd., FUJIFILM Medical Systems Inc., Ziehm Imaging GmbH, Omega Medical Imaging Inc., Allengers Medical Systems Limited.

Europe was the largest region in the angiography equipment market share in 2024. The regions covered in the angiography equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the angiography equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Angiogram equipment is utilized to examine blood vessels and visualize internal organs within the human body. The process involves injecting a radio-opaque contrast agent into the patient's bloodstream and capturing images using X-ray-based methods.

The primary products within the angiography equipment category include angiography systems, angiography catheters, angiography contrast media, vascular closure devices (VCD), angiography balloons, angiography guidewires, and angiography accessories. Angiography equipment, also known as contrast agents or contrast media, enhances the diagnostic value of imaging examinations. The technologies involved in angiography equipment include X-ray angiography, CT angiography, MR angiography, and other advanced imaging technologies. The procedures associated with angiography equipment encompass coronary angiography, endovascular angiography, onco-angiography, and neuro-angiography. These solutions find application across various end-users, including hospitals and clinics, diagnostic and imaging centers, as well as research institutes.

The angiography equipment products market research report is one of a series of new reports that provides Angiography equipment products market statistics, including angiography equipment products industry global market size, regional shares, competitors with angiography equipment products market share, detailed Angiography equipment products market segments, market trends, and opportunities, and any further data you may need to thrive in the angiography equipment products industry. This angiography equipment products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The angiogram equipment market consists of sales of angiography equipment solutions, flat-panel digital detectors and image intensifiers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.